Please assess the completion status of the following clinical trial:

Trial Title: Study of Self or Clinic Administration of DepoProvera

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. age greater than or equal to 18 years~2. seeking DMPA for contraception~3. English or Spanish speaking~4. consistent access to a working telephone~5. availability for follow up for one year~Exclusion Criteria:~1. suspected or continuing pregnancy~2. undiagnosed vaginal bleeding~3. known or suspected breast cancer~4. acute liver disease~5. known hypersensitivity to medroxyprogesterone acetate or any other components of DMPA~6. desire for pregnancy within one year

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Self Administration of DMPA (Type: EXPERIMENTAL): Self administration of subcutaneous depot medroxyprogesterone acetate
- Clinic administration of DMPA (Type: ACTIVE_COMPARATOR): Clinic administration (routine care) of DMPA

Based on this trial design, predict the completion outcome and termination type (if applicable).